Results 51 to 60 of about 200,920 (269)

Las empresas españolas que patentan en la oficina europea [PDF]

open access: yes, 2011
El objetivo de este trabajo es aportar evidencia sobre las características de las empresas españolas que solicitan patentes a la Oficina Europea entre 1998 y 2006, comparándolas con las de otras empresas no solicitantes de patentes durante el mismo ...
Barajas, Ascen   +2 more
core   +2 more sources

Developmental and Epileptic Encephalopathy due to Biallelic Pathogenic Variants in PIGM

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective PIGM encodes a critical enzyme in the glycosylphosphatidylinositol (GPI)‐anchor biosynthesis pathway. While promoter‐region mutations in PIGM have been associated with a relatively mild phenotype characterized by portal vein thrombosis and absence seizures, recent evidence suggests that coding‐region mutations result in a more severe
Júlia Sala‐Coromina   +11 more
wiley   +1 more source

Patenteamento de tecnologias relacionadas a energias renováveis: o caso do biodiesel

open access: yesRevista Tecnologia, 2010
Neste trabalho foi realizado um estudo de tendências tecnológicas sobre biodiesel com base em informações extraídas de documentos de patentes. O termo "documento de patente" abrange pedidos de patente publicados ou patentes concedidas.
Márcia França Fernandes dos Santos   +2 more
doaj  

Low Incidence of Relapses After Vaccination in Anti‐Aquaporin‐4 Antibody‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Patients with neuromyelitis optica spectrum disorder (NMOSD) may experience increased signs and symptoms of their underlying disease when vaccinated against meningococcal disease before receiving complement component 5 inhibitor therapies. This retrospective analysis indicated an overall low relapse incidence (mean [range], 3.3% [0.7%–10.6 ...
Sean J. Pittock   +4 more
wiley   +1 more source

Características de patentes de dispositivos para rehabilitación física registradas en los Estados Unidos

open access: yesRevista Habanera de Ciencias Médicas, 2019
Introducción: La rehabilitación física puede verse beneficiada con el uso de dispositivos, los cuales en su mayoría suelen ser patentados. La oficina de patentes y marcas de los Estados Unidos (USPTO) es una de las oficinas de patentes y marcas más ...
Wendy Nieto-Gutierrez   +5 more
doaj  

Patentando ADN

open access: yesLa Propiedad Inmaterial, 2011
Los sistemas de patentes en los países desarrollados han hecho diferentes interpretaciones o creado nuevos estándares con el fin de adoptar secuencias de ADN como una entidad patentable, independientemente del hecho de que el ADN en principio no cumplía ...
Carlos Augusto Conde Gutiérrez
doaj   +2 more sources

Patentes sobre los genes BRCA-1 y BRCA-2: El caso Myriad [PDF]

open access: yes, 2011
El número de patentes sobre materiales biomédicos y procesos, como líneas celulares, métodos de replicación y pruebas genéticas está aumentando día a día.
Belli, Laura Florencia
core  

Cracking the Code: Genotype–Phenotype Correlation Models in Sarcoglycanopathies

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Sarcoglycanopathies are among the most severe limb‐girdle muscular dystrophies (LGMD), though milder presentations have been described. These diseases are primarily caused by missense variants, but the limited predictability of their effect on protein maturation, complex formation, and transport has hindered reliable genotype ...
Leonela Luce   +72 more
wiley   +1 more source

Núcleo de apoio ao patenteamento: manual de procedimentos. [PDF]

open access: yes, 2011
Patentes; Busca; Redação; Formulários; Cartasbitstream/item/26301/1/DOC14-2005.pdf; bitstream/item/26303/1/DOC14-2005-anexos.pdfAcompanha folheto contendo os ...
GONTOW, R.   +2 more
core  

Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis–Associated Interstitial Lung Disease

open access: yesArthritis Care &Research, EarlyView.
Objective A leading cause of death among patients with scleroderma (SSc), interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M. Padilla   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy